AU2202801A - Antigen preparations - Google Patents

Antigen preparations

Info

Publication number
AU2202801A
AU2202801A AU22028/01A AU2202801A AU2202801A AU 2202801 A AU2202801 A AU 2202801A AU 22028/01 A AU22028/01 A AU 22028/01A AU 2202801 A AU2202801 A AU 2202801A AU 2202801 A AU2202801 A AU 2202801A
Authority
AU
Australia
Prior art keywords
antigen preparations
antigen
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22028/01A
Inventor
Thomas John Baldwin
Christopher Lee Holmes
Cornelia Suzanna Mclean
Simon Swift
Paul Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Cantab Pharmaceuticals Research Ltd
Original Assignee
University of Nottingham
Cantab Pharmaceuticals Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham, Cantab Pharmaceuticals Research Ltd filed Critical University of Nottingham
Publication of AU2202801A publication Critical patent/AU2202801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU22028/01A 1999-12-17 2000-12-18 Antigen preparations Abandoned AU2202801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929923.2A GB9929923D0 (en) 1999-12-17 1999-12-17 Antigen preparations
GB9929923 1999-12-17
PCT/GB2000/004874 WO2001044278A2 (en) 1999-12-17 2000-12-18 Antigen preparations

Publications (1)

Publication Number Publication Date
AU2202801A true AU2202801A (en) 2001-06-25

Family

ID=10866565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22028/01A Abandoned AU2202801A (en) 1999-12-17 2000-12-18 Antigen preparations

Country Status (5)

Country Link
EP (1) EP1237913A2 (en)
JP (1) JP2003516742A (en)
AU (1) AU2202801A (en)
GB (1) GB9929923D0 (en)
WO (1) WO2001044278A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017092842A1 (en) * 2015-12-03 2017-06-08 Merck Patent Gmbh Chemically defined media for the detection of microorganisms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2023448C1 (en) * 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Method for manufacturing vaccine against various pathogenic serotypes of group b neisser's meningitis
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines

Also Published As

Publication number Publication date
JP2003516742A (en) 2003-05-20
WO2001044278A3 (en) 2001-12-27
WO2001044278A2 (en) 2001-06-21
EP1237913A2 (en) 2002-09-11
GB9929923D0 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
AU2001294192A1 (en) Solid preparations
AU1951201A (en) Peptide antigens
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU9623898A (en) Vaccines
AU4935000A (en) Antibodies
AU6045900A (en) Interaction-activated proteins
AU2001242479A1 (en) Proliposomal encapsulated preparations
AU5977700A (en) Vaccines
AU3283500A (en) Tumor-associated antigen
AU2452301A (en) Protein methylarginine-specific antibodies
AU2231601A (en) Vancomycin preparations
AU6158700A (en) Vaccine
AU2001288102A1 (en) Solid preparations
AU3191100A (en) Ligand-bonded complex
AU1800100A (en) Medicinal preparations
AU2001282521A1 (en) OCT preparations
AU2001272427A1 (en) Solid preparations
AU1881200A (en) Novel proteins
AU4553100A (en) Tumour-associated antigen
AU7788600A (en) Colon-tumour-associated antigens
AU5811600A (en) Vaccine
AU1540701A (en) Novel protein
AU5632500A (en) Cancer associated antigens and uses therefor
AU6075498A (en) Vaccines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase